|Bid||13.00 x 900|
|Ask||14.01 x 1000|
|Day's Range||13.60 - 14.10|
|52 Week Range||12.60 - 15.99|
|Beta (3Y Monthly)||N/A|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
CAMBRIDGE, Mass., May 13, 2019 -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address.
CAMBRIDGE, Mass., May 08, 2019 -- Axcella Health Inc., a biotechnology company pioneering the research and development of novel multifactorial interventions to address.
The U.S. initial public offering market is facing its biggest week since 2015 with at least 15 deals expected to price, including Uber, the biggest IPO since Alibaba in 2014 and biggest U.S. company deal since Facebook in 2012.
The Street can't get enough biotechs. Here's the latest firm to join the company of hundreds. The IPO Axcella Health Inc. will issue more than 3.57 million shares on the Nasdaq under ticker AXLA, according ...
For a more comprehensive IPO calendar, check out the offering in Benzinga Cloud . The IPO dates below are expected but not confirmed. Milestone Pharmaceuticals Inc. (MIST) will issue 5 million shares between ...